SUBSCRIBE

Breaking News on Supplements & Nutrition - EuropeUS edition

Headlines > Industry

Pharma players want MHRA-licensed vitamin D prescribed, not supplements

Post a commentBy Sarah Hills , 19-Jun-2014
Last updated on 20-Jun-2014 at 10:17 GMT

Health Food Manufacturers’ Association: 'We are very wary of unnecessary pharma-backed pressures for future guidelines to only recommend licensed vitamin D products, and of course we wholeheartedly disagree'.
Health Food Manufacturers’ Association: 'We are very wary of unnecessary pharma-backed pressures for future guidelines to only recommend licensed vitamin D products, and of course we wholeheartedly disagree'.

New UK guidelines for vitamin D intake in the UK should recommend that only medically licensed products are prescribed and not food supplements, according to several pharma experts.

The call has raised “major concern” for the Health Food Manufacturers’ Association (HFMA), which believed such recommendations would lead to confusion and undermine safe and widely-used ‘unlicensed’ vitamin D products.

Internis Pharmaceuticals, a manufacturer of vitamin D, said that food supplement products were not licensed by the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) and were not therefore subject to its strict control.

The UK’s National Institute for Health and Care Excellence (NICE) has published draft guidance to help improve the implementation of existing recommendations on vitamin D to prevent deficiency.

The guidance focused on advice for at-risk groups to take vitamin D supplements. It also recommended that the Department of Health (DoH) work with manufacturers to ensure wider availability of vitamin D supplements supplying the recommended nutrient intake.

However, three vitamin D specialists - Dr Brian Curwain, Dr Sally Hope and Dr Michael Stone - and firm Internis Pharmaceuticals, said they feared that “unless the guideline makes clear that only licensed vitamin D products should be recommended, prescribed and dispensed”, at-risk groups, such as pregnant women and young children, could receive either a sub-therapeutic or an excessive dose.

Varying composition?

One of the experts, Dr Brian Curwain, an independent pharmaceutical consultant, said: “Food supplements are variable in their composition, both in terms of the active ingredient and potentially allergenic excipients, colours, etc that they contain.

“It is important that NICE acknowledges that there are greater risks to health professionals in terms of their legal responsibility in supplying food supplements than in licensed vitamin D medicines.”

Internis highlighted research that found products without an MHRA licence have a larger variation in the percentage label claim of vitamin D content, compared to licenced products.

HFMA response

Graham Keen, HFMA executive director, told NutraIngredients it and other industry organisations have been working with the DoH regarding messaging on vitamin D products targeting at-risk groups.

He added: “As such, we are very wary of unnecessary pharma-backed pressures for future guidelines to only recommend licensed vitamin D products, and of course we wholeheartedly disagree.

“This is a major concern as it has the potential to cause confusion over what is an extremely important public health issue, as well as ruin the great existing work to help increase essential supplementation consumption. 

“There are a wide range of vitamin D products, including food supplements, that have an exceptional record of safety and efficacy, and which play a big role in helping prevent deficiencies here in the UK and should continue to do so in the future.”

Public consultation on the draft guidance closes on 24 June and final guidance is expected in November.

Subscribe to our FREE newsletter

Get FREE access to authoritative breaking news, videos, podcasts, webinars and white papers. SUBSCRIBE

Post a comment

Comment title *
Your comment *
Your name *
Your email *

We will not publish your email on the site

I agree to Terms and Conditions

These comments have not been moderated. You are encouraged to participate with comments that are relevant to our news stories. You should not post comments that are abusive, threatening, defamatory, misleading or invasive of privacy. For the full terms and conditions for commenting see clause 7 of our Terms and Conditions ‘Participating in Online Communities’. These terms may be updated from time to time, so please read them before posting a comment. Any comment that violates these terms may be removed in its entirety as we do not edit comments. If you wish to complain about a comment please use the "REPORT ABUSE" button or contact the editors.

Related products

Key Industry Events

 

Access all events listing

Our events, Events from partners...